Table 4. Grade 3 or 4 AEs considered to be related to the Cidofovir and chemoradiotherapy combination (weeks 1 to 10) in the 15 patients.
G3-4 AEs | Tota | Related to treatment |
---|---|---|
N (%) | N (%) | |
Abdominal pain | 3 | 2 |
Infection | 2 | 1 |
Leukoneutropenia | 2 | 2 |
Proteinuria | 1 | 1 |
Myalgia | 1 | 0 |
Vaginal bleeding | 1 | 0 |
Asthenia | 1 | 0 |
Insomnia | 1 | 0 |
Hyperglycemia | 1 | 0 |
AEs: adverse events, N: number of patients.